From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to etravirine (TMC125):: Fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase

被引：89

作者：

De Corte, BL ^{[1
]}

机构：

[1] Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2005年 / 48卷 / 06期

关键词：

D O I：

10.1021/jm040127p

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：1689 / 1696

页数：8

共 58 条

[1] TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1 [J].

Andries, K ;

Azijn, H ;

Thielemans, T ;

Ludovici, D ;

Kukla, M ;

Heeres, J ;

Janssen, P ;

De Corte, B ;

Vingerhoets, J ;

Pauwels, R ;

de Béthune, MP .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) :4680-4686

[2]

Arnold E, 1996, Drug Des Discov, V13, P29

[3] Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent [J].

Balzarini, J ;

Naesens, L ;

Verbeken, E ;

Laga, M ;

Van Damme, L ;

Parniak, M ;

Van Mellaert, L ;

Anné, J ;

De Clercq, E .

AIDS, 1998, 12 (10) :1129-1138

[4] Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1 [J].

Balzarini, J .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (09) :921-944

[5] ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].

BARRESINOUSSI, F ;

CHERMANN, JC ;

REY, F ;

NUGEYRE, MT ;

CHAMARET, S ;

GRUEST, J ;

DAUGUET, C ;

AXLERBLIN, C ;

VEZINETBRUN, F ;

ROUZIOUX, C ;

ROZENBAUM, W ;

MONTAGNIER, L .

SCIENCE, 1983, 220 (4599) :868-871

[6] Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: Retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptase [J].

Borkow, G ;

Barnard, J ;

Nguyen, TM ;

Belmonte, A ;

Wainberg, MA ;

Parniak, MA .

JOURNAL OF VIROLOGY, 1997, 71 (04) :3023-3030

[7] Synthesis and anti-HIV activity of 1,3,4,5-tetrahydro-2H-1,4-benzodiazepin-2-one (TBO) derivatives.: Truncated 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-ones (TIBO) analogues [J].

Breslin, HJ ;

Kukla, MJ ;

Kromis, T ;

Cullis, H ;

De Knaep, F ;

Pauwels, R ;

Andries, K ;

De Clercq, E ;

Janssen, MAC ;

Janssen, PAJ .

BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (11) :2427-2436

[8]

BRESLIN HJ, 1995, J MED CHEM, V38, P771, DOI 10.1021/jm00005a005

[9] Crystallography and the design of anti-AIDS drugs: Conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors [J].

Das, K ;

Lewi, PJ ;

Hughes, SH ;

Arnold, E .

PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2005, 88 (02) :209-231

[10] Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants [J].

Das, K ;

Clark, AD ;

Lewi, PJ ;

Heeres, J ;

de Jonge, MR ;

Koymans, LMH ;

Vinkers, HM ;

Daeyaert, F ;

Ludovici, DW ;

Kukla, MJ ;

De Corte, B ;

Kavash, RW ;

Ho, CY ;

Ye, H ;

Lichtenstein, MA ;

Andries, K ;

Pauwels, R ;

de Béthune, MP ;

Boyer, PL ;

Clark, P ;

Hughes, SH ;

Janssen, PAJ ;

Arnold, E .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (10) :2550-2560

← 1 2 3 4 5 6 →